RenBio (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 20, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $24,000,000
Company Info
- Organizations Involved
- Defense Advanced Research Projects Agency, Bill and Melinda Gates Foundation, MedImmune
- Founders
- Dr. Yaoxing Huang
- Company Description
- RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases.
- Market
- Antiviral therapeutics
- Location
- New York, NY, USA
- Coinvestors
- Ruentex Group